Chelsea Therapeutics (Comparative Multiple Analysis)
Improve your investment analysis with by seeing the Chelsea Therapeutics's Discounted Cash Flow analysis, Chelsea Therapeutics's Warren Buffet analysis, and Chelsea Therapeutics's Weighted Average Cost of Capital (WACC) Analysis.
Notes on the Comparative Multiple Analysis of Chelsea Therapeutics
WikiWealth compares Chelsea Therapeutics's revenue, EBITDA, and EBIT multiples to their peers in order to determine the appropriate fair valuation. Click in the top right corner to experiment with Chelsea Therapeutics's comparative analysis.
Notes from the analysis:
1. WikiWealth uses quantitative measures to determine the multiple range for Chelsea Therapeutics.
Helpful Information for Chelsea Therapeutics's Analysis
How does this work? The Comparative Investment Analysis determines the value of Chelsea Therapeutics by comparing Chelsea Therapeutics financial ratios, prices, growth rates, margins, etc. to those of relevant peer groups.
Value Investing Importance? This method is widely used by investment professionals to determine the correct price of investments, especially initial public offerings (IPOs). It is one element of WikiWealth's three Wall Street approaches used to determine the correct fair value of Chelsea Therapeutics.
Also, see the Chelsea Therapeutics's buffett intrinsic valuation analysis for WikiWealth's attempt to replicate the investing formula's used by Warren Buffett and Chelsea Therapeutics's valuation conclusion for a quick summary.